Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
Conditions: Heart Failure NYHA Class II; Heart Failure NYHA Class III; Heart Failure Intervention: Sponsors: University of Pennsylvania; Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials